← Open Payments lookup

JILL OLMSTEAD: Open Payments

NPI 1740276732 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,940 in 74 payments from 14 companies in 2025. Trend: 2023 $3,270 · 2024 $11,962 · 2025 $5,940

Consulting: $3,863Food & beverage: $2,078
CompanyPaymentsAmount
Phathom Pharmaceuticals, Inc.4$2,763
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$1,474
ABBVIE INC.19$354
Madrigal Pharmaceuticals9$333
Ardelyx, Inc.9$289
Ipsen Biopharmaceuticals, Inc3$155
Janssen Biotech, Inc.7$153
Gilead Sciences, Inc.7$146
Regeneron Healthcare Solutions, Inc.2$97
PFIZER INC.4$73

Products named: VOQUEZNA, TRULANCE, REZDIFFRA, IBSRELA, SKYRIZI, RINVOQ, IQIRVO, TREMFYA.

Industry payments across CA — which companies pay providers there.